1.The result of rehabilitation nursing of the patients with total hip replacement
Chinese Journal of Rehabilitation Medicine 2001;16(2):120-121
Objective:To understand the effect and significance of rehabilitation nursing of the patients with total hip replacement. Method:In view of the rehabilitation nursing procedure, functional training before and after the operation were performed in 34 cases with total hip replacement. Result:21 cases made completely recovery; 9 cases complete independent living ;3 cases almost independent living; l case partial dependent, and no complications. Conclusion: Scientific rehabilitation nursing plan can decrease the incidence rate of complications after the operation and promotes functional recover to patients with total hip replacement.
2.Observation on Therapeutic Efficacy of Western Medicine in Combination with Traditional Chinese Medicine for Treating Viralmyocarditis
Journal of Medical Research 2006;0(06):-
Objective To observe the therapeut ic efficacy of compound salviae m ilt io rrh igae inject ion and ast ragalus inject ion on viralmyocardit is.Methods 36 viralmyocardit patient' s were randomly divided into two groups :The control group was treated with Potassium Aspaytate and Magnesium Aspartate Injection 30ml+Insulin 8U added to 5% glucose solution 500ml and ATP 20mg+CoA 100 U+Vit C 500mg added to 10% glucose solution 30 ml for intravenous drip once daily;plus Chinese herbal medicine were taken orally in treatment group.Results The effective rates were 89.5% and 76.4% in treatment group and control group respectively.There was obvious difference between 2 groups(P
3.Green tea in chemoprevention of prostate cancer
Journal of International Oncology 2008;35(10):786-789
Green tea as a main beverage is consumed worldwide. In the last few years, .green tea has been shown to induce apoptosis and to inhibit the infiltration and metastasis of prostate cancer by in vitro and in vivo experiments. Epidemiologic investigations and clinical trials also have demonstrated the chemopreventive role of green tea in prostate cancer, such as reducing the possibility of carcinogenesis of high-grade prostatic in-traepithelial neoplasia, and is hopeful to be applied as chemopreventive agent of prostate cancer in the future.
5.Research progress of traditional Chinese medicine extract for retinal ischemia -reperfusion injury
International Eye Science 2015;(5):810-812
?Retinal ischemia - reperfusion injury ( RlRl ) is a common clinical disease, and the producing mechanism is still in research. Experimental and clinical research in recent years have showed that the mechanism of RlRl and oxygen free radicals, gene regulation, calcium overload, inflammatory cytokines and other factors are closely related. ln this article, we summarized the current situation that the scholars at home and abroad study traditional Chinese medicine extract of prevention and treatment of RlRl.
6.Curative effects of pure radiotherapy and concurrent chemotherapy and radiotherapy for patients with cerical cancer
Xiaoling QIN ; Yuling JIA ; Yingna BAO
Journal of International Oncology 2016;43(6):428-432
Objective To investigate the curative effects and adverse reactions of pure radiotherapy and concurrent chemotherapy and radiotherapy for patients with cervical cancer.Methods One hundred and twenty-seven patients with cervical cancer who accepted treatment in the Affliated Hospital of Inner Mongolia Medical Unive.rsity from May 2010 to May 2012 were collected.All patients were divided into two groups:pure radiotherapy group (n =65) and concurrent chemotherapy and radiotherapy group (n =62).The curative effects,adverse reactions and survival of two groups were observed.Results All patients were completed treatment.The median follow-up time was 42 months.The rate of complete response in the pure radiotherapy group was 80.0% (52/65),and the rate in the concurrent chemotherapy and radiotherapy group was 82.26% (51/62),with no significant difference (x2 =1.22,P =0.352).The 1-year overall survival rates in the pure radiotherapy group and the concurrent chemotherapy and radiotherapy group were 95.38% and 95.16% respectively,with no significant difference (x2 =0.32,P =0.533),but the 3-year overall survival rates were 81.54% and 90.32% respectively,the 5-year overall survival rates were 72.31% and 83.87% respectively,with significant differences (x2 =5.09,P =0.015;x2=3.87,P =0.039).However,for the patients who were ≥ 60 years,the 1-year overall survival rates in the two groups were 94.62% and 93.91% respectively,the 3-year overall survival rates were 85.02% and 87.25% respectively,the 5-year overall survival rates were 70.06% and 73.58% respectively,with no significant differences (x2 =0.06,P =0.753;x2 =1.16,P =0.279;x2 =0.48,P =0.511).The adverse reactions were mainly in grades 1-2.There were significant differences in the rates of leucopenia (56.10% vs.72.20%),thrombocytopenia (58.82% vs.76.80%),nausea and vomiting (34.04% vs.56.90%) among the two treatment groups (x2 =11.23,P =0.003;x2 =11.82,P=0.002;x2 =12.77,P =0.000).Conclusion The curative effect of concurrent chemotherapy and radiotherapy is better than that with pure radiotherapy for patients with cervical cancer,which can improve the 3-year and 5-year overall survival.But at the same time,it should be noted that the rates of adverse reactions may be increased during the same period.For the age of 60 or more patients with cervical cancer,concurrent chemotherapy and radiotherapy does not achieve even greater survival benefit.
7.Research progress of Yttrium-90 in the treatment of unresectable and chemotherapy-tolerant colorectal liver metastasis
Zhongzhi JIA ; Chunfu ZHU ; Xihu QIN
Chinese Journal of Digestive Surgery 2016;15(2):200-202
Colorectal liver metastasis (CRLM) is a common liver metastatic tumor with poor prognosis.It was very difficult to treat patients with unresectable and chemotherapytolerant CRLM.With the tumor control rate ranging from 63% to 78%,Yttrium-90 is both safe and effective in treating unresectable and chemotherapy-tolerant CRLM.The median survival time is 10.5 months,and the 1-,2-,3-year overall survival rates of patients are 44%,20% and 14% respectively.For a certain portion of patients,Yttrium-90 has distinct advantages over mo lecular targeted drugs and other local minimally invasive treatment.Though Yttrium-90 treatment has showed certain curative effect,its safety and effectiveness require further confirmation through multi-center randomized controlled trial.
8.Clinical observation of arsenic trioxide plus all trans retinoic acid versus ATRA combined with chemotherapy treatment on acute promyelocytic leukemia
Jia WAN ; Dabing QIN ; Jieping CHEN
Chongqing Medicine 2014;(31):4185-4187
Objective To observe the efficacy of arsenic trioxide(ATO) combined all trans retinoic acid (ATRA) versus cytara‐bine (Ara‐C) combined ATRA in the treatment of acute promyelocytic leukemia(APL) .Methods We enrolled 65 patients in our department during the period between January 2002 and August 2008 ,and they were randomly assigned to receive ATRA combined ATO (treatment group ,n= 27) or ATRA combined DA ,HA ,NA which were major of Ara‐C (control group ,n= 38) .Then observe the differences of between the two groups ,such as complete remission(CR) ,the time to complete remission ,overall survival(OS) ,e‐vent free survival(EFS) ,the 5 years disease free survival (DFS) and adverse reactions .Results The CR rate of treatment group (ATRA + ATO) and control group (chemotherapy + ATRA) was 81 .48% and 68 .42% ,respectively ,and the time to complete re‐mission was (28 .50 ± 3 .97)d and (30 .56 ± 2 .39)d ,respectively ,showed that there was no statistical difference between the two groups ( P > 0 .05 ) .The 5 years DFS of the CR patients in the two groups was 51 .9% (ATRA + ATO ) and 50 .0%(Chemotherapy + ATRA) ,respectively ,showed that there was no statistical difference between the two groups(P > 0 .05) .The 5 years EFS of the CR patients in the two groups was 48 .1% and 39 .5% ,respectively ,showed that there was no statistical difference between the two groups(P> 0 .05) .The 5 years DFS of the patients in the two groups was 55 .6% and 67 .6% ,respectively ,showed that there was no statistical difference between the two groups(P > 0 .05) .Bone marrow suppression in the treatment group was significantly lower than in the control group(P< 0 .05) .Conclusion ATRA + ATO can prolong the CR rate ,OS ,EFS and 5 years EFS of newly diagnosed APL patients .ATRA combined with chemotherapy has similar efficacy ,ATRA + ATO has lower bone marrow suppression than the ATRA combined with chemotherapy ,thus may reduce the risk of early death .
9.Effect of ATAD2 on metastasisand epithelial-mesenchymal transition of human glioblastoma cell lines
Yanchang QIN ; Dong JIA ; Qingwei YU
Basic & Clinical Medicine 2017;37(4):512-517
Objective To analyze the effect of ATAD2 on glioma cell lines.Methods ATAD2 level in U87MG, U251 and normal human astrocytes was detected by RT-PCR and Western blot.U87MG and U251 cells were divided into four groups: control, mock (lipofection control), ATAD2 siRNA (transfected with ATAD2 siRNA) and ATAD2 overexpression (transfected with ATAD2).Cell proliferation, migration and invasion were respectively measured by MTT and Transwell assay.The level of E-cadherin, N-cadherin and Vimentin was measured by Western blot.Results ATAD2 was highly expressed in U87MG and U251 cells.Compared with control, cell proliferation, invasion, migration, N-cadherin and Vimentin expression were decreased by ATAD2 siRNA, while they were promoted by ATAD2 overexpression (P<0.05).E-cadherin expression was upregulated by ATAD2 siRNA and it was inhibited by ATAD2 overexpression (P<0.05).Conclusions ATAD2 participants in human glioma cells metastasis via epithelial-mesenchymal transition (EMT).
10.Comments on the Expert Consensus of Cantonese and Eeastern Hepatobiliary Surgical Hospitals on hepatocellular carcinoma with portal vein tumor thrombus
Zhongzhi JIA ; Chunfu ZHU ; Xihu QIN
Chinese Journal of Hepatobiliary Surgery 2016;22(10):649-650
Hepatocellular carcinoma with portal vein tumor thrombus (PVTT),an advanced stage of disease,is common.Patients who have hepatocellular carcinoma (HCC) with PVTT have a poor outcome.The management of HCC with PVTT is a clinical challenge.Although many treatment options are available,there are currently no consensus or guideline on optimal management of HCC with PVTT.To improve understanding of the two guidelines published recently,we compared the similarities and differences between them.